LEADER 03394nam  22006612  450 
001 9910452668803321
005 20151005020622.0
010   $a1-139-88824-2
010   $a1-139-57936-3
010   $a1-139-57335-7
010   $a1-139-56898-1
010   $a1-139-04762-0
010   $a1-139-57079-X
010   $a1-139-57254-7
010   $a1-283-63859-2
010   $a1-139-56988-0
035   $a(CKB)2550000000707802
035   $a(EBL)1025027
035   $a(OCoLC)812196813
035   $a(SSID)ssj0000753491
035   $a(PQKBManifestationID)11496599
035   $a(PQKBTitleCode)TC0000753491
035   $a(PQKBWorkID)10814129
035   $a(PQKB)11020115
035   $a(UkCbUP)CR9781139047623
035   $a(MiAaPQ)EBC1025027
035   $a(Au-PeEL)EBL1025027
035   $a(CaPaEBR)ebr10608446
035   $a(CaONFJC)MIL395105
035   $a(EXLCZ)992550000000707802
100   $a20110304d2012||||  uy|            0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExclusions from patentability $ehow far has the European Patent Office eroded boundaries? /$fSigrid Sterckx and Julian Cockbain$b[electronic resource]
210  1$aCambridge :$cCambridge University Press,$d2012.
215   $a1 online resource (xxix, 341 pages) $cdigital, PDF file(s)
225 1 $aCambridge intellectual property and information law ;$v19
300   $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
311   $a1-107-54262-6 
311   $a1-107-00694-5 
320   $aIncludes bibliographical references and index.
327   $a1. Introduction -- 2. The historical development and current scope of the European Patent Convention -- 3. Computer programs -- 4. Discoveries -- 5. Methods of medical treatment and diagnosis -- 6. Essentially biological processes for the production of plants and animals -- 7. Plant and animal varieties -- 8. Morality and 'ordre public' -- 9. Towards a coherent interpretation of the exclusions -- 10. Conclusion.
330   $aExclusions from Patentability reviews the history of the adoption of exclusions from patentability under the European Patent Convention since its first conception in 1949 through to its most recent revision. The analysis shows how other intellectual property treaties, such as UPOV, the Strasbourg Patent Convention, PCT, the EU Biotech Directive and TRIPS have affected the framing of the exclusions. Particular attention is given to those exclusions considered the most contentious (computer programmes, discoveries, medical treatments, life forms and agriculture) and those decisions which have been most influential in shaping the approaches by which the exclusions have been interpreted. The 'morality' exclusion and the interpretation of the exclusions are discussed critically and suggestions for coherent interpretation are made.
410  0$aCambridge intellectual property and information law ;$v19.
606   $aPatent laws and legislation$zEurope
615  0$aPatent laws and legislation
676   $a346.2404/86
700   $aSterckx$b Sigrid$01035214
702   $aCockbain$b Julian
801  0$bUkCbUP
801  1$bUkCbUP
906   $aBOOK
912   $a9910452668803321
996   $aExclusions from patentability$92454793
997   $aUNINA